These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Recommendations for use of everolimus after heart transplantation: results from a Latin-American Consensus Meeting. Bocchi EA; Ahualli L; Amuchastegui M; Boullon F; Cerutti B; Colque R; Fernandez D; Fiorelli A; Olaya P; Vulcado N; Perrone SV Transplant Proc; 2006 Apr; 38(3):937-42. PubMed ID: 16647515 [TBL] [Abstract][Full Text] [Related]
15. Prevention of acute rejection and allograft vasculopathy by everolimus in cardiac transplants recipients: a 24-month analysis. Viganò M; Tuzcu M; Benza R; Boissonnat P; Haverich A; Hill J; Laufer G; Love R; Parameshwar J; Pulpón LA; Renlund D; Abeywickrama K; Cretin N; Starling RC; Eisen HJ; J Heart Lung Transplant; 2007 Jun; 26(6):584-92. PubMed ID: 17543781 [TBL] [Abstract][Full Text] [Related]
16. Everolimus: a review of its use in renal and cardiac transplantation. Dunn C; Croom KF Drugs; 2006; 66(4):547-70. PubMed ID: 16597167 [TBL] [Abstract][Full Text] [Related]
17. Everolimus and long-term outcomes in renal transplantation. Campistol JM; de Fijter JW; Nashan B; Holdaas H; Vítko S; Legendre C Transplantation; 2011 Aug; 92(3 Suppl):S3-26. PubMed ID: 21799392 [No Abstract] [Full Text] [Related]
18. Pharmacodynamic effects of everolimus on anti-CD3 antibody-stimulated T-lymphocyte proliferation and interleukin-10 synthesis in stable kidney-transplant patients. Böhler T; Waiser J; Lichter S; Schumann B; Neumayer HH; Kamar N; Budde K Cytokine; 2008 Jun; 42(3):306-11. PubMed ID: 18440821 [TBL] [Abstract][Full Text] [Related]
19. Considerations in sirolimus use in the early and late post-transplant periods. Patel SJ; Elliott EN; Knight RJ; Gaber LW; Gaber AO Expert Opin Drug Saf; 2009 Jul; 8(4):421-34. PubMed ID: 19522662 [TBL] [Abstract][Full Text] [Related]
20. New drug application 21-628, Certican (everolimus), for the proposed indication of prophylaxis of rejection in heart transplantation: report from the Cardiovascular and Renal Drugs Advisory Committee, US Food and Drug Administration, November 16, 2005, Rockville, Md. Hiatt WR; Nissen SE; Circulation; 2006 Mar; 113(10):e394-5. PubMed ID: 16534016 [No Abstract] [Full Text] [Related] [Next] [New Search]